Synovus Financial’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $453K | Sell |
1,442
-1,207
| -46% | -$379K | 0.01% | 691 |
|
|
2025
Q1 | $807K | Buy |
2,649
+1,148
| +76% | +$350K | 0.01% | 525 |
|
|
2024
Q4 | $499K | Sell |
1,501
-209
| -12% | -$69.4K | 0.01% | 643 |
|
|
2024
Q3 | $571K | Sell |
1,710
-257
| -13% | -$85.8K | 0.01% | 650 |
|
|
2024
Q2 | $810K | Sell |
1,967
-174
| -8% | -$71.7K | 0.01% | 496 |
|
|
2024
Q1 | $865K | Sell |
2,141
-33
| -2% | -$13.3K | 0.01% | 489 |
|
|
2023
Q4 | $666K | Buy |
2,174
+493
| +29% | +$151K | 0.01% | 527 |
|
|
2023
Q3 | $407K | Buy |
1,681
+326
| +24% | +$78.9K | ﹤0.01% | 664 |
|
|
2023
Q2 | $325K | Sell |
1,355
-90
| -6% | -$21.6K | ﹤0.01% | 708 |
|
|
2023
Q1 | $272K | Sell |
1,445
-550
| -28% | -$103K | ﹤0.01% | 739 |
|
|
2022
Q4 | $424K | Buy |
1,995
+28
| +1% | +$5.95K | ﹤0.01% | 650 |
|
|
2022
Q3 | $306K | Sell |
1,967
-1,435
| -42% | -$223K | ﹤0.01% | 703 |
|
|
2022
Q2 | $502K | Sell |
3,402
-682
| -17% | -$101K | 0.01% | 586 |
|
|
2022
Q1 | $660K | Buy |
4,084
+1,492
| +58% | +$241K | 0.01% | 540 |
|
|
2021
Q4 | $569K | Sell |
2,592
-469
| -15% | -$103K | 0.01% | 604 |
|
|
2021
Q3 | $587K | Buy |
3,061
+101
| +3% | +$19.4K | 0.01% | 569 |
|
|
2021
Q2 | $530K | Buy |
2,960
+20
| +0.7% | +$3.58K | 0.01% | 598 |
|
|
2021
Q1 | $475K | Buy |
+2,940
| New | +$475K | 0.01% | 563 |
|
|
2020
Q2 | – | Sell |
-123
| Closed | -$9K | – | 1904 |
|
|
2020
Q1 | $9K | Buy |
+123
| New | +$9K | ﹤0.01% | 1590 |
|